Historical record - last NADAC effective date: 7/17/2024
Product Information
FEVERALL 325 MG SUPPOSITORY is a brand product labeled by Sun Pharmaceutical Industries Inc., priced at $0.6986 per EA under NDC 51672211604. Its NADAC has been published 227 times since Feb 18, 2015.
FDA first approved this application before 1982.
The High Outlier badge above means this manufacturer's average price in the Acetaminophen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
325 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672211604
Classification
Brand
Dosage Form
SUPPOSITORY
Route
RECTAL
Effective Date
7/17/2024
Active Ingredients
ACETAMINOPHENApproval Type
New Drug (NDA)
FDA Application
NDA018337FDA Approved
Before 1982
On Market Since
12/12/2013
Price Statistics
The NADAC for FEVERALL 325 MG SUPPOSITORY has been published 227 times since Feb 18, 2015, and over the history we have for it it has declined 11.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6986 per EA |
|---|---|
| All-time high | $0.7903 (Mar 16, 2016) |
| All-time low | $0.6776 (Mar 20, 2024) |
| Median price | $0.6933 |
| Average price | $0.7155 |
| Largest weekly change | -12.7% (Apr 22, 2020) |
| Weeks tracked | 227 |
| Tracking since | Feb 18, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+1.8%
5Y
+0.8%
All
-11.6%
Last surveyed Aug 14, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FEVERALL 325 MG SUPPOSITORY?
The current National Average Drug Acquisition Cost (NADAC) for FEVERALL 325 MG SUPPOSITORY, manufactured by Sun Pharmaceutical Industries Inc., is $0.6986 per EA (NDC 51672211604), effective Aug 14, 2024.
How has the price of FEVERALL 325 MG SUPPOSITORY changed over time?
Over the history we have for it, the NADAC for FEVERALL 325 MG SUPPOSITORY has declined 11.6%. It has been tracked across 227 weekly CMS publications since Feb 18, 2015.
What are the highest and lowest recorded NADAC prices for FEVERALL 325 MG SUPPOSITORY?
Since Feb 18, 2015, the NADAC for FEVERALL 325 MG SUPPOSITORY has ranged from a low of $0.6776 (Mar 20, 2024) to a high of $0.7903 (Mar 16, 2016), with a median of $0.6933 per EA.
Are there cheaper alternatives to FEVERALL 325 MG SUPPOSITORY?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FEVERALL 325 MG SUPPOSITORY in a comparable dosage form, but none are currently priced below it.
Who manufactures FEVERALL 325 MG SUPPOSITORY?
FEVERALL 325 MG SUPPOSITORY (NDC 51672211604) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a brand product.